Launching a comprehensive review of strategic opportunities – In the fourth quarter of 2024, Atea engaged an independent global investment bank to assist the Company in identifying potential ...

By hoodwinking seniors into private Medicare Advantage plans, insurers profit by denying care and bankrupting hospitals.

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates of microbial resistance rise.

The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in ...

BrainStorm Cell Therapeutics Inc. , a leading biotechnology company committed to the development and commercialization of best-in-class autologous cellular therapies for the treatment of ...

DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...

Shares of Inovio Pharmaceuticals Inc. INO slid 3.72% to $1.81 Tuesday, on what proved to be an all-around positive trading ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Me on Sunday filed for bankruptcy, prompting a consumer alert from Utah's Department of Commerce's Division of Consumer ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Subscribers can delete their accounts at any time by going to the account settings on the 23andMe website or mobile app.

The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...